Dr Robert Paproski
Position:
- Post Doctoral Fellow, Department of Oncology, University of Alberta
Biography:
Dr Robert Paproski received his B.Sc. (pharmacology) and PhD (oncology) at the University of Alberta. He is currently supervised by Dr Roger Zemp and Dr John Lewis and works on a variety of projects including developing new uses for ultrasound in oncology.
Dr Paproski’s main research interests include using ultrasound to induce pore formation in cancer cell membranes (sonoporation) which can liberate biomarkers (proteins/RNA) as well as allow cytoplasmic entry of therapeutics.
He is also developing specialized perfluorocarbon-based ultrasound contrast agents (called nanodroplets) which are smaller than currently used microbubbles. These smaller nanodroplets have the ability to accumulate in tumours due to the enhanced permeability and retention effect, potentially allowing enhanced detection of tumours with ultrasound.
Ultrasound, Imaging, Biomarkers, Microparticles, Nanoparticles.
